Category:
Cardiovascular System Drugs
CAS NO:
184475-35-2
Standard:
ChP,
Treat Cancer-Lung cancer
Gefitinib is a small-molecule tyrosine kinase inhibitor targeting EGFR, synthesized via multi-step organic reactions. Its molecular formula is C22H24ClFN4O3, CAS No. 184475-35-6.
Restricted to patients with EGFR mutations; contraindicated in severe hepatic impairment. Store below 25°C in dry conditions away from direct light to maintain stability.